Status | Study |
Not yet recruiting |
Study Name: Secured Access to Nivolumab for Adult Patients With Selected Rare Cancer Types Condition: Carcinoma, Renal Cell Head and Neck Neoplasm Skin Neoplasm Date: 2017-01-02 Interventions: Drug: Nivolumab Treatment Other Name: Opdivo |
Not yet recruiting |
Study Name: Development of Diagnostics and Treatment of Urological Cancers Condition: Prostate Carcinoma Kidney Cancer Urothelial Carcinoma Date: 2016-12-01 Interventions: Other: Personalised treatment Treatment based on NGS or DSRT |
Recruiting |
Study Name: E7 TCR T Cells With or Without PD-1 Blockade for Human Papillomavirus-Associated Cancers Condition: Cervical Cancer Vaginal Cancer Anal Cancer Date: 2016-08-04 Interventions: Biological: E7 TCR Transduced PBL cells |
Active, not recruiting |
Study Name: Evaluation of Lymphadenectomy and Chemotherapy TIP on Inguinal Lymph Nodes in Squamous Cell Carcinoma of the Penis Condition: Penile Cancer Squamous Carcinoma Date: 2016-05-24 Interventions: Drug: Chemotherapie TIP Paclitaxel, ifosfamide and cisplatine |
Recruiting |
Study Name: Cabozantinib-s-malate and Nivolumab With or Without Ipilimumab in Treating Patients With Metastatic Genitourinary Tumors Condition: Clear Cell Renal Cell Carcinoma Metastatic Malignant Neoplasm in the Bone Date: 2015-07-08 Interventions: Drug: Cabozantinib S-malate Gi |
Completed |
Study Name: A Trial of Cabazitaxel Chemotherapy in Relapsed Locally Advanced &/or Metastatic Carcinoma of the Penis Condition: Penile Neoplasm Date: 2014-10-30 Interventions: Drug: Cabazitaxel Six cycles of chemotherapy comprising: |
Completed |
Study Name: T Cell Receptor Immunotherapy Targeting HPV-16 E6 for HPV-Associated Cancers Condition: Vaginal Cancer Cervical Cancer Anal Cancer Date: 2014-10-30 Interventions: Drug: Fludarabine Patients wil |
Active, not recruiting |
Study Name: A Phase II Trial of Vinflunine Chemotherapy in Locally-advanced and Metastatic Carcinoma of the Penis (VinCaP) Condition: Locally-advanced or Metastatic Penile Neoplasms Date: 2014-02-05 Interventions: Drug: Vinflunine All patients will receive on Day 1 of a 21 day cycle, vinflunine 320mg/m2 via intraveno |
Withdrawn |
Study Name: Efficacy and Safety of Cetuximab in Metastatic Penile Carcinoma (PENILANE) Condition: Squamous Cell Carcinoma of the Penis Date: 2013-12-05 Interventions: Drug: Cetuximab |
Recruiting |
Study Name: Integrated Cancer Repository for Cancer Research Condition: Pancreatic Cancer Thyroid Cancer Lung Cancer Date: 2013-12-02 |